Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Video

What are the side effects of an allo transplant?

Posted by
HealthTree Logo HealthTree
• July 8, 2025

Description

Learn about side effects of allogeneic transplant in this HealthTree University lesson by cancer specialists.

On this video

Transcript

What are the side effects of an allo transplant?

So the allogeneic transplant, as opposed to the autologous transplant, has a much higher rate of this entity called graft versus host disease. Those patients need to be on immune suppression to try to prevent graft versus host disease for a much longer period of time. There's a earlier form of graft versus host disease that can be treated starting with prednisone, that can be taken over a period of weeks. But the later form, which is called the late or chronic graft versus host disease, can last for a period of years. Some patients are on immunosuppression for a long time.

The type of symptoms of the early graft versus host disease can be skin rash, can be diffuse skin rash, nausea, vomiting, diarrhea, can be some liver abnormalities. And then later abnormalities are dryness of the eye is dry, and some amounts of sores in the mouth, sensitivity in the mouth, breathing difficulties, liver difficulties, intestinal or vaginal symptoms can be all part of a complex of chronic graft responses, including a skin change which is different. The skin can become stiff and joint. It can be joint stiffness and lack of flexibility. So it can be quite a number of symptoms with the later more chronic diseases.

What questions about allogeneic transplant should I be asking my doctor when thinking about allo transplant?

So at this time, it's not considered standard for myeloma patients to be considering allogeneic transplant. So it would be only the high-risk patients, usually the younger high-risk patients, are the patients for whom we're considering allogeneic transplant who have the poor-risk side genetics and who are young otherwise, without no other medical conditions. So usually the most myeloma specialists would be identifying those patients who could potentially be considered for that. And usually those transplants are being done on a clinical trial or in a center that specializes in that. So it would not be a general question for most myeloma patients.

Related Content